Hope you are right on Pt 2 but my take
is JB indicated on last call that 118335
could be a very important compound
and that they wanted to take their time
and “get it right”... so I was thinking they
run and complete the other planned ones
for reversal of recent and long term anti psych
Users and then run a comprehensive ph 3
For broad label usage...
Will have to wait and see what their strategy is
for this indication....
Pt 3) totally can’t understand why shorts haven’t
covered more as it seems like patent litigation
is more even if not tilting Corcepts way...